Altimmune Shares Drop After $225 Million Offering Prices

Altimmune shares dropped after the biopharmaceutical company priced an underwritten public offering consisting of 64.3 million shares and accompanying warrants to buy 64.3 million shares. Shares were ...

Spruce Biosciences Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Spruce Biosciences, Inc. ("Spruce Biosciences") (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with ...
USA Today

Datavault AI Announces Change in Distribution Date for Warrants to Purchase Common Stock to Eligible Record Equityholders of Datavault AI to February 23, 2026

PHILADELPHIA, PA / ACCESS Newswire / February 13, 2026 / Datavault AI Inc. (NASDAQ:DVLT) (“Datavault AI” or the “Company”), a provider of data monetization, credentialing, digital engagement, and real ...

Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants

Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the ...
Stocktwits on MSN

Dilution fears return: Why ALT stock is getting hit again

The offering is at a 13.5% discount to the stock’s closing price on Wednesday. ・Altimmune plans to use the proceeds to support its Phase 3 trial of Pemvidutide in MASH, a liver disease. ・The Phase 3 ...